tiprankstipranks
Pyxis Oncology (PYXS)
NASDAQ:PYXS
US Market
Holding PYXS?
Track your performance easily

Pyxis Oncology (PYXS) Technical Analysis

386 Followers

Technical Sentiment

Overall Consensus
Buy
11Bullish
6Neutral
5Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Pyxis Oncology’s (PYXS) Moving Averages Convergence Divergence (MACD) indicator is 0.22, suggesting Pyxis Oncology is a Sell.
Pyxis Oncology’s (PYXS) 20-Day exponential moving average is 4.02, while Pyxis Oncology’s (PYXS) share price is $4.19, making it a Buy.
Pyxis Oncology’s (PYXS) 50-Day exponential moving average is 3.79, while Pyxis Oncology’s (PYXS) share price is $4.19, making it a Buy.

Pyxis Oncology (PYXS) Pivot Points

Nov 22, 2024, 03:30 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
3.79
3.95
4.12
4.28
4.45
4.61
4.78
Fibonacci
3.95
4.08
4.16
4.28
4.41
4.49
4.61
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pyxis Oncology (PYXS) Moving Averages

Nov 22, 2024, 03:30 PM
Period
Simple
Exponential
MA5
4.42Sell
4.29Sell
MA10
4.22Sell
4.20Sell
MA20
3.96Buy
4.02Buy
MA50
3.69Buy
3.79Buy
MA100
3.57Buy
3.69Buy
MA200
4.06Buy
3.69Buy
Pyxis Oncology’s (PYXS) 10-Day exponential moving average is 4.20, while Pyxis Oncology’s (PYXS) share price is $4.19, making it a Sell.
Pyxis Oncology’s (PYXS) 100-Day exponential moving average is 3.69, while Pyxis Oncology’s (PYXS) share price is $4.19, making it a Buy.
Pyxis Oncology’s (PYXS) stock price is $4.19 and Pyxis Oncology’s (PYXS) 50-day simple moving average is 3.69, creating a Buy signal.
Pyxis Oncology’s (PYXS) stock price is $4.19 and Pyxis Oncology’s (PYXS) 100-day simple moving average is 3.57, creating a Buy signal.
Pyxis Oncology’s (PYXS) stock price is $4.19 and Pyxis Oncology’s (PYXS) 200-day simple moving average is 4.06, creating a Buy signal.

Pyxis Oncology (PYXS) Technical Indicators

Nov 22, 2024, 03:30 PM
Name
Value
Implied Action
RSI (14)
56.86
Neutral
STOCH (9,6)
33.96
Neutral
STOCHRSI (14)
37.73
Neutral
MACD (12,26)
0.22
Sell
ADX (14)
35.08
Neutral
Williams %R
-65.55
Buy
CCI (14)
53.26
Neutral
ATR (14)
0.32
-
Ultimate Oscillator
38.57
Neutral
ROC
10.55
Buy
Pyxis Oncology’s (PYXS) Relative Strength Index (RSI) is 56.86, creating a Neutral signal.
Pyxis Oncology’s (PYXS) Trend Strength Indicator (ADX) is 35.08, creating a Neutral signal.
Pyxis Oncology’s (PYXS) Commodity Channel Index (CCI) is 53.26, creating a Neutral signal.
Pyxis Oncology’s (PYXS) Price Rate of Change (ROC) is 10.55, creating a Buy signal.

FAQ

Is PYXS a Buy, Hold, or Sell?
Based on PYXS’s technical indicators, PYXS is a Buy.
    What is PYXS’s RSI (14)?
    PYXS’s RSI (14) is 56.86, which suggests PYXS is a Neutral.
      What is PYXS’s MACD?
      PYXS’s MACD is 0.22, which suggests PYXS is a Sell.
        What is PYXS’s 5-day moving average?
        PYXS’s 5-day moving average is 4.42, which suggests PYXS is a Sell.
          What is PYXS’s 20-day moving average?
          PYXS 20-day moving average is 3.96, which suggests PYXS is a Buy.
            What is PYXS’s 50-day moving average?
            PYXS’s 50-day moving average is 3.69, which suggests PYXS is a Buy.
              What is PYXS’s 200-day moving average?
              PYXS’s 200-day moving average is 4.06, which suggests PYXS is a Buy.
                What is PYXS’s Williams % R (14)?
                PYXS’s Williams % R (14) is -65.55, which suggests PYXS is a Buy.
                  What is PYXS’s CCI (14)?
                  PYXS’s CCI (14) is 53.26, which suggests PYXS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis